“…30 Besides its therapeutic utility, it has also shown promise as a positron emission tomography-computed tomography (PET/CT) agent to diagnose the progress of cervical carcinoma and has successfully cleared clinical human trial phase II recently. 31,32 Following the successful story of 64 Cu(ATSM), a number of copper bis(thiosemicarbazone) complexes with different radio- labeled nuclides, 60 Cu, 61 Cu, 62 Cu, and 64 Cu, have been tested as PET/CT imaging agents. 33−37 Recently, we have shown that the ligand bis-(thiosemicarbazone) of glyoxal (GTSCH 2 ) can be used for live cell imaging in conjunction with zinc.…”